Vectorite Biomedical (4170.TWO) Stock Price
Vectorite Biomedical Price
Over the last 15 years Vectorite Biomedical grew revenue by 18.2% annually, reaching 61.41 M TWD. Earnings per share have grown at 9.5% per year over the last 11 years. For Vectorite Biomedical, the net margin of 156.6% is up versus 29.1% a few years ago.
Vectorite Biomedical stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Vectorite Biomedical business model & stock analysis
Frequently asked questions about Vectorite Biomedical
Converted at the current exchange rate, the Vectorite Biomedical share trades at 0.33 EUR (11.95 TWD).
The revenue cannot currently be calculated for Vectorite Biomedical.
The profit cannot currently be calculated for Vectorite Biomedical.
The P/E ratio cannot be calculated for Vectorite Biomedical at the moment.
The P/S cannot be calculated for Vectorite Biomedical currently.
The Eulerpool Quality Score for Vectorite Biomedical is 5/10.
The ISIN of Vectorite Biomedical is TW0004170006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Vectorite Biomedical is 4170.TWO. The ticker symbol is used to trade Vectorite Biomedical shares on the stock exchange.
Vectorite Biomedical stock
Vectorite Biomedical Peer Group
All fundamentals and in-depth analysis of Vectorite Biomedical
Our stock analysis for Vectorite Biomedical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vectorite Biomedical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.